Compare AstraZeneca plc (AZN) vs Boeing Co (BA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AstraZeneca plc vs Boeing Co — how do they compare? AstraZeneca plc trades at $158.2 (market cap $248.14B), while Boeing Co trades at $233.93 (market cap $184.35B). The key difference: AstraZeneca plc is the larger of the two by market cap, and AstraZeneca plc pays the higher dividend (2.01%). Which is the better fit depends on your goals.
| AZN | BA | |
|---|---|---|
Market Cap | $248.14B | $184.35B |
Sector | Health | Industrials |
52-Week High | $209.48 | $252.15 |
52-Week Low | $147.06 | $179.12 |
Enterprise Value | $275.41B | $210.23B |
Dividend Yield | 2.01% | 0.03% |
Volume | — | 7,591,579 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AstraZeneca plc
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →About Boeing Co
The Boeing Company, together with its subsidiaries, develops, produces, and markets commercial jet aircraft, as well as provides related support services to the commercial airline industry worldwide. The Company also researches, develops, produces, modifies, and supports information, space, and defense systems, including military aircraft, helicopters and space and missile systems.
Read more on BA →
